Companies that have good tech, like AI or ways to monitor patients from home, are attracting a lot of buyer interest as ...

With Qfitlia and Cablivi, Sanofi reaches its fourth and fifth approvals in China this year, following Tzield for stage 2 type ...

"I’m dead in the water if I don’t have a project, whether building something or researching a topic that is my new ...